In this week’s issue:
- Please see attached email from the Office of the Vice-President Research & International regarding a second call for nominations for NSERC’s E.W.R. Steacie Memorial Fellowships.
- Canadian Institutes of Health Research – Innovative Ebola Research Grants
- Cystic Fibrosis Foundation – Clinical Research Awards
- Department of Defense – Lung Cancer Research Program
- Weston Brain Institute – Rapid Response 2015
- Canadian Institutes of Health Research – Operating Grant: Canadian Developmental Origins of Health and Disease (DOHaD) Cohort Registry
Awards and Honours:
- Prostate Cancer Foundation – Stupski Prize in Prostate Cancer Computational Oncology
- Centre for Blood Research Seminar Series – Receptor-mediated endocytosis in megakaryocyte development
- Biomedical Research Centre Seminar Series – Dr. Judah Denburg: In situ hemopoiesis in allergic inflammation and disease: from serendipity to prediction (reminder)
- UBC SPARC Office – NSERC Collaborative Research and Development (CRD) Grants Workshop (reminder)
- UBC SPARC Office – CIHR 2015 Foundation Scheme Information Session
Registration Deadline: May 25, 2015
Full Application Deadline: June 8, 2015
The specific objectives of this funding opportunity are to support innovative research projects relating to Ebola Virus Disease (EVD) with achievable outcomes, and with strong potential to have an impact on the management of EVD in the current outbreak, or to prevent or improve the response to potential future EVD outbreaks, by the end of the funding period.
CIHR will provide funding for applications that are determined to be relevant to the following research areas:
- Ebola biology specifically in the areas of disease pathophysiology and virus replication
- Ebola treatment, specifically in the areas of: antivirals, novel compounds, biologicals, convalescent plasma, rehydration and electrolyte replacement, clinical management of severe acute disease)
- Transmission, spread, containment and prevention of Ebola, specifically in the areas of: vaccines; rapid diagnostic technologies; development of enhanced early warning, mathematical modeling, and enhanced disease mapping methods; evaluating the effectiveness of preventive and containment measures to contain or prevent the spread of Ebola
- Study of the impacts of the Ebola crisis on health system utilization patterns by different population groups in affected regions; the cost-effectiveness of health system resource development strategies in response to the Ebola crisis; the sustainability of health workforce and other health system resource allocation strategies once the Ebola crisis subsides.
The total amount available for this funding opportunity is $2,400,000. This amount may increase if additional funding partners participate. The maximum amount per grant is $250,000 for up to one (1) year.
Webinars: There will be 2 information webinars to learn more about this funding opportunity. For questions about the registration process, please contact Melanie Brule at firstname.lastname@example.org.
- April 28th 2:00 -3:00pm EST (Register here)- Presented by Nancy Edwards (CIHR-IPPH)
- May 4th, 2:30-3:30pm EST (Register here)- Presented by Jennifer Raven(CIHR-III) and Danielle Arsenault (CIHR-IPPH)
Full details on this funding opportunity, including application deadlines and instructions, can be found at https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=2248.
LOI Deadline: June 1, 2015; 2pm PST
Full Application Deadline: September 9, 2015
Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the CF Foundation, offers competitive awards to support clinical research projects directly related to CF treatment and care.
Projects may address diagnostic or therapeutic methods related to CF or the pathophysiology of CF, and applicants must demonstrate access to a sufficient number of CF patients from CF Foundation-accredited care centers and to appropriate controls.
Up to $100,000 per year (plus 8% indirects) for a maximum of three years may be requested for single-center clinical research grants. For multi-center clinical research, the potential award is up to $225,000 per year (plus 8% indirects) for a maximum of three years.
For trials exceeding these limitations, please contact Cystic Fibrosis Foundation Therapeutics before submission.
For further information, please visit the Cystic Fibrosis Foundation website.
Department of Defense – Lung Cancer Research Program
Pre-Application Deadline: June 2, 2015
Full Application Deadline: September 16, 2015
The Department of Defense has recently announced 3 funding opportunities within its Lung Cancer Research Program (LCRP).
- Career Development Award
- Clinical Exploration Award
- Idea Development Award
Full details for LCRP Opportunities available at http://cdmrp.army.mil/funding/lcrp.shtml.
LOI Deadline: June 16, 2015; 2pm EDT
The Weston Brain Institute is delighted to launch its Rapid Response 2015 program to provide seed funding for totally novel, high-risk, high-reward translational research ideas to catalyze the development of safe and effective treatments for neurodegenerative diseases of aging. Each project may receive up to $150,000 over 12-18 months
Applicants must be researchers or postdoctoral fellows, and developing a therapeutic and/or a tool to help accelerate the development of therapeutics for neurodegenerative diseases of aging.
Submission of the Letter of Intent is done through the Institute’s online grant management system at https://weston.smartsimple.ca/welcome/neuroscience.
The Weston Brain Institute will be holding a Program Information Session for this funding opportunity on May 20th at 1:00 PM. This session is intended to provide you with comprehensive information on the application process and to provide an opportunity for open questions.
To sign-up for the WebEx and receive the dial in details as well as submit any questions you may have in advance, please follow the link https://www.surveymonkey.com/s/YX22TJS
The Institute welcomes inquiries about our funding programs at email@example.com or 416-935-4056.
Additional information about the Program can be found at http://westonbraininstitute.ca/funding-opportunities/2015-rapid-response/.
Application Deadline: October 1, 2015
The purpose of this funding opportunity is to create a Registry of DOHaD cohort studies that will provide a database of metadata and definition of variables from all relevant Canadian cohorts, thereby linking them in a way that facilitates larger and better powered studies.
The specific objectives of the registry are to:
- Create a user-friendly, effective platform to support data interoperability and improve harmonization practices;
- Accelerate research and reduce cost by leveraging collaborative and/or cross-disciplinary research among Canadian researchers and their international collaborators;
- Broaden research perspectives by enabling national and international large-scale collaborative analyses.
The total amount available for this funding opportunity is $1,300,000 over 5 years or a maximum of $260,000 per annum – enough to fund one grant. This amount may increase if additional funding partners confirm their participation in this initiative.
Full details on this funding opportunity, including application deadlines and instructions, can be found at https://www.researchnet-recherchenet.ca/rnr16/viewOpportunityDetails.do?prog=2252.
AWARDS AND HONOURS:
Prostate Cancer Foundation – Stupski Prize in Prostate Cancer Computational Oncology
The Prostate Cancer Foundation is pleased to announce the Stupski Prize in Prostate Cancer Computational Oncology, a first-in-field initiative designed to attract novel ideas to the field of cancer bioinformatics. These solutions will help clinicians and researchers optimize treatment for individual prostate cancer patients and will likely lead to breakthroughs in other cancers as common molecular drivers are uncovered.
A total of five $25,000 prizes will be awarded over the next two years. Additional details on this initiative may be found in the official press release at http://www.pcf.org/stupski-prize.
The inaugural Stupski Prize was awarded to Nikolaus Schultz, PhD, for his work developing the cBioPortal for Cancer Genomics. Future prizes will be awarded as a result of global, crowdsourced competitions. All interested parties are encouraged to sign up on the PCF website to be notified of upcoming Stupski Prize competitions: http://www.pcf.org/stupski/email.
Centre for Blood Research Seminar Series – Receptor-mediated endocytosis in megakaryocyte development
Date & Time: April 29, 2015; 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Hervé Falet
Instructor, Harvard Medical School
Associate Biologist, Brigham and Women’s Hospital
Blood platelets are produced by bone marrow megakaryocytes in a process that requires extensive membrane rearrangements. These include the formation of the demarcation membrane system, the surface‐connected membrane extension that invaginates into the cell body and elaborates to provide membranes for future platelets. Our current research is focused on the cellular mechanisms and membrane binding and deforming proteins involved in the formation of this unique internal membrane system. In this talk, we will highlight our recent efforts to characterize the role of the large GTPase dynamin 2 and the F‐BAR protein PACSIN2 in receptor‐mediated endocytosis required for megakaryocyte development and platelet production.
Please contact Dr. Hugh Kim (firstname.lastname@example.org) to network with the guest speaker.
Date & Time: May 4, 2015; 4-5pm
Location: Biomedical Research Centre, 2222 Health Sciences Mall, Vancouver
Dr. Judah Denburg
Director, Division of Clinical Immunology and Allergy, Department of Medicine
William J. Walsh Professor of Medicine
Scientific Director, AllerGen-NCE Inc.
Hosted by Dr. Kelly McNagny Kelly@brc.ubc.ca
Date & Time: May 4, 2015; 1-3pm
Location: Room 101, Michael Smith Laboratories, 2185 East Mall, Vancouver
The SPARC Office is pleased to announce it is once again organizing an NSERC Collaborative Research and Development (CRD) Grants Workshop for UBC researchers interested in applying to this valuable research partnership funding program.
Jeffery Nerenberg, Senior Manager, Research Partnerships, from the NSERC-Ottawa office will be coming to UBC on Monday, May 4th, 2015 to give a presentation, meet with researchers and address any questions you may have related to the NSERC CRD program. In addition to Mr. Nerenberg, some successful UBC CRD applicants will also outline and discuss their experiences with the CRD program.
This information session is scheduled for:
1:00 – 3:00pm on Monday, May 4th, and additional information is available on the Event Registration webpage on the SPARC website.
Please NOTE: Registration for this Workshop is REQUIRED. Lunch will be provided.
If you have any questions or concerns, please feel free to forward them to David Woods (email@example.com) in the SPARC Office.
Date & Time: May 14, 2015; 1-4pm
Location: UBC Point Grey campus (location TBA), with videoconference connections to hospital sites and UBC Okanagan
The SPARC Office has arranged a CIHR 2015 Foundation Scheme Information Session, hosted by Dr. Lara Boyd. The target audience is brand-new 2015 applicants and grant facilitators/research support staff who are not yet familiar with the Foundation Scheme.
For full details and to register for the May 14th session, please visit the Information Session announcement at http://sparc.ubc.ca/programs/cihr-2015-foundation-scheme-information-session-may-14th-1-4pm-0.
If you have any questions, please call or email Christy McTait at 604-827-5615 or firstname.lastname@example.org.